Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant
Thomas Ebensen1, Rimma Libanova, Kai Schulze
1Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany. thomas.ebensen@helmholtz-hzi.de
Vaccine
|May 31, 2011
Summary
Bis-(3',5')-cyclic dimeric adenosine monophosphate (c-di-AMP), a bacterial molecule, acts as a potent mucosal adjuvant. It enhances both antibody and cellular immune responses, showing promise for new vaccine development.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- Effective adjuvants are crucial for enhancing subunit vaccine performance.
- Mucosal vaccine delivery offers advantages but requires potent adjuvants.
Purpose of the Study:
- To investigate the adjuvant potential of bis-(3",5")-cyclic dimeric adenosine monophosphate (c-di-AMP) for mucosal vaccine applications.
- To evaluate the immunomodulatory effects of c-di-AMP on innate and adaptive immune cells.
Main Methods:
- In vitro studies on murine macrophages and dendritic cells (DCs) from murine and human origins.
- Intranasal co-administration of c-di-AMP with antigens (β-galactosidase or OVA) in BALB/c and C57BL/6 mice.
- Assessment of humoral immunity (serum IgG, secretory IgA) and cellular immunity (T cell responses, CTLs).
Main Results:
- c-di-AMP stimulated macrophages and promoted DC activation and maturation.
- Intranasal c-di-AMP significantly increased antigen-specific IgG and secretory IgA.
- Robust cellular immune responses, including Th1/Th2/Th17 balance and CTL activity, were induced.
Conclusions:
- c-di-AMP demonstrates strong adjuvant properties for mucosal vaccine delivery.
- It effectively enhances both humoral and cellular immunity, including cytotoxic T lymphocyte (CTL) responses.
- c-di-AMP holds significant potential for developing next-generation mucosal vaccines, especially those requiring cellular immunity.
More Related Videos
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Adrenergic Agonists: Direct-Acting Agents
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...


